Volition announces clinical research study with oncovet

Henderson, nev. , nov. 14, 2022 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, has announced a clinical research study with oncovet, a renowned veterinary referral clinic, specializing in medical and radiation oncology.
VNRX Ratings Summary
VNRX Quant Ranking